LDT409: In Vitro and In Vivo Data on a Cardanol Derivative for Chagas Disease

A 38.3 KB PDF data sheet authored by Juliana Magalhães Chaves Barbosa, last updated March 18, 2026. It presents results from evaluating the trypanocidal and immunomodulatory effects of LDT409, a synthetic cardanol derivative from cashew nut shell liquid, using in vitro assays and an in vivo murine model of acute Chagas disease.

Use Cases

• Evaluating trypanocidal activity of natural product derivatives based on in vitro assay results.
• Analyzing immunomodulatory effects on Th1/Th2/Th17 immune profiles based on murine model data.
• Investigating the role of PPAR agonists in host-parasite interactions for Chagas disease.
• Comparing the potential efficacy and cost-effectiveness of new compounds against current treatments like benznidazole.

Strengths

• Data is openly licensed under CC-BY-4.0.
• The description provides a detailed scientific context for the experimental results.
• File size is 38.3 KB, allowing for quick download and review.

Limitations

• Row count and column-level documentation are unknown, limiting suitability assessment.
• The dataset is a single 38.3 KB PDF, suggesting a limited scope of presented results.
• The underlying mechanisms of the observed effects, such as PPAR involvement, are noted as unclarified.

Provenance

Source

figshare, author Juliana Magalhães Chaves Barbosa.

Collection Method

Data likely originates from in vitro assays and an in vivo murine model of acute Chagas disease.

Freshness

Last updated 2026-03-18 05:21:45; freshness should be verified.